Hypertrophic Cardiomyopathy

Clinical Trial Finder

Many patients with hypertrophic cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Nitrite in Hypertrophic Cardiomyopathy (HCM) Study

Condition:   Cardiomyopathy, Hypertrophic
Interventions:   Drug: Sodium Nitrate;   Drug: Placebo;   Diagnostic Test: Phosphorous Magnetic Resonance Spectroscopy;   Diagnostic Test: Exercise Stress Transthoracic Echocardiogram
Sponsors:   University of East Anglia;   Norfolk and Norwich University Hospitals NHS Foundation Trust;   British Medical Research Council
Recruiting - verified August 2017

Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve

Conditions:   Hypertrophic Cardiomyopathy;   Non-ischemic Dilated Cardiomyopathy;   Microvascular Ischaemia of Myocardium
Interventions:   Drug: Regadenoson;   Drug: Adenosine
Sponsor:   Duke University
Not yet recruiting - verified August 2017

Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias

Conditions:   Inherited Cardiac Arrythmias;   Long QT Syndrome (LQTS);   Brugada Syndrome (BrS);   Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT);   Early Repolarization Syndrome (ERS);   Arrhythmogenic Cardiomyopathy (AC, ARVD/C);   Hypertrophic Cardiomyopathy (HCM);   Dilated Cardiomyopathy (DCM);   Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy);   Normal Control Subjects
Sponsor:   Johns Hopkins University
Enrolling by invitation - verified August 2017